Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dose escalation study of tezacitabine in combination with cisplatin in patients with advanced cancer.

Dose escalation study of tezacitabine in combination with cisplatin in patients with advanced cancer. Cancer. 2003 Apr 15; 97(8):1985-90.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.